Using of dexmedetomidine in term neonates with hypoxic-ischemic encephalopathy.
Author:
Open Access
- 18 June 2019
- journal article
- research article
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 24 (2) , 24-33
Abstract
Using of dexmedetomidine in term neonates with hypoxic-ischemic encephalopathy.Keywords
This publication has 34 references indexed in Scilit:
- Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart SurgeryAnesthesia & Analgesia, 2016
- Neuroprotection for Perinatal Hypoxic Ischemic Encephalopathy in Low- and Middle-Income CountriesThe Journal of Pediatrics, 2015
- Near-infrared spectroscopy: Applications in neonatesSeminars in Fetal and Neonatal Medicine, 2015
- Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of AgePediatrics & Neonatology, 2015
- Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialBMJ, 2015
- Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysisThe Lancet, 2015
- A Phase II/III, Multicenter, Safety, Efficacy, and Pharmacokinetic Study of Dexmedetomidine in Preterm and Term NeonatesThe Journal of Pediatrics, 2014
- Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990Pediatric Research, 2013
- A Dose-Response Study of Dexmedetomidine Administered as the Primary Sedative in Infants Following Open Heart SurgeryPediatric Critical Care Medicine, 2013
- Pain and Sedation in the NICUNeoReviews, 2013